AngioDynamics Announces the Release of the Dynamic Flow Chronic Hemodialysis CatheterQUEENSBURY, N.Y.--(BUSINESS WIRE)--June 17, 2004--AngioDynamics, Inc., (Nasdaq:ANGO) today announced its release of the Dynamic Flow^™ chronic hemodialysis catheter. Designed for long-term use in dialysis patients, the Dynamic Flow catheter, which had been offered in limited markets, is now being offered throughout the United States.

The Dynamic Flow chronic hemodialysis catheter features a split tip design and a proximal shaft that reduces the chance of kinking after placement. The catheter also features a Durathane^™ shaft - a biocompatible and durable material that offers higher chemical resistance than polyurethane, which helps simplify site care since the material can be cleaned with either iodine or alcohol.

Commenting for AngioDynamics, Don Geer, Director, Vascular Access Products, said, "The introduction of the Dynamic Flow chronic hemodialysis catheter reflects our ongoing commitment to helping physicians treat patients with chronic renal failure. We believe this product will be an important and successful addition to our growing line of dialysis products."

For additional information on the Dynamic Flow catheter, contact Don Geer at 1-800-772-6446, ext. 167, Email: dgeer@angiodynamics.com or visit the AngioDynamics web site at www.angiodynamics.com.

About AngioDynamics

AngioDynamics, Inc. (www.angiodynamics.com) designs, develops, manufactures and markets innovative medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease. It offers a broad line of therapeutic and diagnostic devices that enable interventional physicians, such as interventional radiologists, vascular surgeons and others, to treat peripheral vascular diseases and other non-coronary diseases. AngioDynamics' diversified product line includes angiographic catheters, hemodialysis catheters, PTA dilation catheters, thrombolytic products, image-guided vascular access products, endovascular laser venous system products, as well as drainage products. AngioDynamics is a majority-owned subsidiary of E-Z-EM, Inc. (AMEX:EZM), a leading manufacturer of contrast agents for gastrointestinal radiology.

The statements made in this document contain certain forward-looking statements that involve a number of risks and uncertainties. Words such as "expects", "intends", "anticipates", "plans", "believes", "seeks", "estimates," or variations of such words and similar expressions, are intended to identify such forward-looking statements. Investors are cautioned that actual events or results may differ from the Company's expectations. In addition to the matters described above, the ability of the Company to develop its products, market acceptance and future sales of the Dynamic Flow^™ chronic hemodialysis catheter, future actions by the FDA or other regulatory agencies, results of pending or future clinical trials, overall economic conditions, general market conditions, market acceptance, foreign currency exchange rate fluctuations, the effects on pricing from Group Purchasing Organizations, competition, including alternative procedures which continue to replace traditional fluoroscopic procedures, as well as the risk factors listed from time to time in the SEC filings of E-Z-EM, Inc., including but not limited to its Form 10-Q for the quarter ended February 28, 2004, as well as its Annual Report on Form 10-K for the year ended May 31, 2003, may affect the actual results achieved by the Company.

    CONTACT: AngioDynamics, Inc.
             Lisa Donegan, (800) 772-6446 x370
             http://www.angiodynamics.com
               or
             Investor Relations Contacts:
             Lippert/Heilshorn & Associates, Inc.
             Kim Sutton Golodetz (kgolodetz@lhai.com)
             (212) 838-3777
             Bruce Voss (bvoss@lhai.com)
             (310) 691-7100

    SOURCE: AngioDynamics, Inc.